Molecular Instruments Revenue and Competitors
Estimated Revenue & Valuation
- Molecular Instruments's estimated annual revenue is currently $5.7M per year.
- Molecular Instruments's estimated revenue per employee is $155,000
Employee Data
- Molecular Instruments has 37 Employees.
- Molecular Instruments grew their employee count by 9% last year.
Molecular Instruments's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CEO | Reveal Email/Phone |
2 | Head Operations and Product Development Lead | Reveal Email/Phone |
3 | VP Commercial | Reveal Email/Phone |
4 | Administrative Manager | Reveal Email/Phone |
5 | Business Development Manager | Reveal Email/Phone |
6 | Product Manager | Reveal Email/Phone |
7 | Research Scientist | Reveal Email/Phone |
8 | Technology Lead and Head Technology Support | Reveal Email/Phone |
9 | Manufacturing Associate | Reveal Email/Phone |
10 | Senior Product Associate | Reveal Email/Phone |
Molecular Instruments Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Molecular Instruments?
Molecular Instruments (MI) designs and synthesizes kits for multiplexed quantitative bioimaging in academic research, drug development, and clinical pathology and diagnostics. MI offers custom assay design and development services for life sciences and pharmaceutical companies.
keywords:N/AN/A
Total Funding
37
Number of Employees
$5.7M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 37 | -3% | N/A |
#2 | $4.3M | 37 | 16% | N/A |
#3 | $3.5M | 37 | -3% | N/A |
#4 | $673.9M | 37 | -76% | $20M |
#5 | $4.3M | 37 | N/A | N/A |